Recently, Center for Medical Device Evaluation.NMPA issued a notice on publicly soliciting opinions on the Guidelines for the Evaluation of Recombinant Humanized Collagen Raw Materials (Draft for Comments):
All relevant units:
According to the relevant requirements of the preparation and revision plan of the Guiding Principles for the 2022 Annual Medical Device Registration Review of the NMPA, our Center has organized the preparation of the Guiding Principles for the Evaluation of Recombinant Humanized Collagen Raw Materials. After investigation and discussion, a draft for comments (Attachment 1) has been formed, which will be publicly available online from now on.
If you have any comments and suggestions, please fill in the Feedback Form (Appendix 2) and send it to our center by email before December 2, 2022. Please name the subject of the email and the name of the document in the format of “Feedback+Name of Feedback Unit” in the Guidelines for the Evaluation of Recombinant Humanized Collagen Raw Materials (Draft for Comments).
